Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

M
2017-09-19
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$15.54-4,4001,170,7450%-$68,354
M
2017-09-18
CASICasi Pharmaceuticals, Inc.He Wei-WuDirP - Purchase$1.75+207,5022,860,204+8%+$364,149
D
2017-09-19
ONCESpark Therapeutics, Inc.Faga DanielChief Business OfficerS - Sale+OE$85.00-1,5000-100%-$127,500
2017-09-19
MBOTMicrobot Medical Inc.Bornstein YosephDir, 10%S - Sale$1.18-50,0005,195,409-1%-$59,233
D
2017-09-18
BCRXBiocryst Pharmaceuticals IncCohen Fred EDirS - Sale+OE$5.42-54,250119,410-31%-$294,035
DM
2017-09-15
BOLDAudentes Therapeutics, Inc.Patterson Matthew RPres, CEOS - Sale+OE$25.06-10,000186,814-5%-$250,561
D
2017-09-15
BOLDAudentes Therapeutics, Inc.Nagler DavidSVP, HR, Corp. AffairsS - Sale+OE$25.00-3,7500-100%-$93,750
DM
2017-09-15
RGNXRegenxbio Inc.Hayden Donald J JrDirS - Sale+OE$28.70-40,0000-100%-$1,148,000
2017-09-15
RGNXRegenxbio Inc.Vasista VittalCFOS - Sale$27.39-5,00097,283-5%-$136,925
M
2017-09-14
CASICasi Pharmaceuticals, Inc.He Wei-WuDirP - Purchase$1.33+315,3272,652,702+13%+$419,178
2017-09-15
ATRAAtara Biotherapeutics, Inc.Haqq ChristopherEVP, R, D, Chief Scientific OfS - Sale$15.30-6,000369,305-2%-$91,800
D
2017-09-14
BLUEBluebird Bio, Inc.Maraganore JohnDirS - Sale+OE$131.21-18,8685,843-76%-$2,475,733
2017-09-14
JUNOJuno Therapeutics, Inc.Cassidy Bernard JGC, SecretaryS - Sale$44.92-28,00077,893-26%-$1,257,766
2017-09-13
JUNOJuno Therapeutics, Inc.Azelby RobertEVP, Chief Commercial OfficerS - Sale$44.95-12,85037,439-26%-$577,608
2017-09-12
XLRNAcceleron Pharma IncRovaldi ChristopherSVP, Program Mgmt, OpsS - Sale$38.41-14,00026,967-34%-$537,786
M
2017-09-12
XLRNAcceleron Pharma IncKumar RavindraSVP, Chief Scientific OfficerS - Sale$38.42-5,11390,214-5%-$196,418
M
2017-09-12
XLRNAcceleron Pharma IncQuisel John DSVP, Corp. Dev., GC, Sec.S - Sale$38.42-5,11357,310-8%-$196,423
2017-09-12
XLRNAcceleron Pharma IncSherman Matthew LEVP, Chief Medical OfficerS - Sale$38.41-18,40086,500-18%-$706,799
2017-09-12
XLRNAcceleron Pharma IncMcLaughlin Kevin FSVP, CFO, TreasurerS - Sale$38.41-16,00049,300-25%-$614,546
D
2017-09-12
BLUEBluebird Bio, Inc.Vachon MarkDirS - Sale+OE$126.82-6,0002,000-75%-$760,923
D
2017-09-12
ONCESpark Therapeutics, Inc.Faga DanielChief Business OfficerS - Sale+OE$82.50-6,0000-100%-$495,009
2017-09-12
MBOTMicrobot Medical Inc.Bornstein YosephDir, 10%S - Sale$1.12-20,0005,204,7990%-$22,400
2017-09-13
NKNantkwest, Inc.Gorlin SteveDirS - Sale$5.93-39,604768,000-5%-$234,729
M
2017-07-20
VYGRVoyager Therapeutics, Inc.Ravina BernardChief Medical OfficerS - Sale$12.87-16,47032,943-33%-$211,914
D
2017-09-11
BLUEBluebird Bio, Inc.Walsh Jeffrey T.Chief FinancialS - Sale+OE$125.73-4,90027,305-15%-$616,065
D
2017-09-11
SGENSeattle Genetics Inc /waSiegall Clay BPres, CEOS - Sale+OE$53.49-18,832678,129-3%-$1,007,257
D
2017-09-08
SGENSeattle Genetics Inc /waHimes Vaughn BChief Technical OfficerS - Sale+OE$53.22-10,000164,906-6%-$532,190
M
2017-09-08
NKNantkwest, Inc.Gorlin SteveDirS - Sale$6.04-103,841807,604-11%-$627,417
2017-09-12
CDTXCidara Therapeutics, Inc.Stein JeffreyPres, CEOP - Purchase$6.79+7,350255,968+3%+$49,907
D
2017-09-08
TECHBio-Techne CorpLucas Roger CDirS - Sale+OE$120.94-1001,970-5%-$12,094
D
2017-09-08
RGNXRegenxbio Inc.Yoo StephenChief Medical OfficerS - Sale+OE$25.00-27,3420-100%-$683,550
D
2017-09-07
GILDGilead Sciences IncWashington Robin LEVP, CFOS - Sale+OE$85.00-51,820113,079-31%-$4,404,700
D
2017-09-07
ONCESpark Therapeutics, Inc.Faga DanielChief Business OfficerS - Sale+OE$85.02-3,0000-100%-$255,045
D
2017-09-07
BOLDAudentes Therapeutics, Inc.Orbimed Advisors LLC10%S - Sale+OE$22.35-5,0004,801,6380%-$111,750
2017-09-06
SGENSeattle Genetics Inc /waSimpson Todd ECFOS - Sale$52.00-9,638218,377-4%-$501,176
D
2017-09-06
SGENSeattle Genetics Inc /waCline Darren SEVP, CommercialS - Sale+OE$51.94-5,02477,230-6%-$260,967
2017-09-07
JUNOJuno Therapeutics, Inc.Klausner RichardDirS - Sale$42.66-12,000776,985-2%-$511,865
D
2017-09-06
TECHBio-Techne CorpHolbrook Karen ADirS - Sale+OE$121.73-1,059914-54%-$128,909
M
2017-09-06
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$15.02-4,4001,175,1450%-$66,066
D
2017-09-06
NBIXNeurocrine Biosciences IncLippoldt DarinGCS - Sale+OE$60.00-10013,157-1%-$6,000
D
2017-09-06
NBIXNeurocrine Biosciences IncGano KyleChief Business Development OffS - Sale+OE$60.00-4,60773,246-6%-$276,420
D
2017-09-06
NBIXNeurocrine Biosciences IncBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$60.00-26,250129,601-17%-$1,575,000
2017-09-06
MBOTMicrobot Medical Inc.Bornstein YosephDir, 10%S - Sale$1.01-45,6105,224,799-1%-$45,859
2017-08-30
MBOTMicrobot Medical Inc.Bornstein YosephDir, 10%S - Sale$1.07-10,0005,270,4090%-$10,653
M
2017-08-24
MBOTMicrobot Medical Inc.Bornstein YosephDir, 10%S - Sale$1.06-25,0005,280,4090%-$26,523
D
2017-09-05
NBIXNeurocrine Biosciences IncObrien Christopher FlintCHIEF MEDICAL OFFICERS - Sale+OE$57.50-52,81748,973-52%-$3,036,978
D
2017-09-05
RGNXRegenxbio Inc.Hayden Donald J JrDirS - Sale+OE$24.95-20,0000-100%-$499,000
DM
2017-09-05
RGNXRegenxbio Inc.Yoo StephenChief Medical OfficerS - Sale+OE$25.00-32,6580-100%-$816,450
2017-09-05
RGNXRegenxbio Inc.Mills Kenneth T.Pres, CEOS - Sale$25.00-10,500118,530-8%-$262,500
D
2017-09-01
GILDGilead Sciences IncMartin John CExec COBS - Sale+OE$83.11-73,3332,996,766-2%-$6,094,992
D
2017-09-01
GILDGilead Sciences IncAlton Gregg HEVP Comm, Acs ALA, Corp, Med AS - Sale+OE$83.05-25,00076,488-25%-$2,076,188
M
2017-09-01
EDITEditas Medicine, Inc.Bosley KatrinePres, CEOS - Sale$20.33-16,6661,407,763-1%-$338,831
2017-09-05
TROVTrovagene, Inc.Tennant StanleyDirS - Sale$0.69-8,334209,394-4%-$5,750
2017-09-05
VYGRVoyager Therapeutics, Inc.Ravina BernardChief Medical OfficerS - Sale$10.00-5,49017,157-24%-$54,900
D
2017-09-05
ONCESpark Therapeutics, Inc.La Barge JosephGCS - Sale+OE$81.00-5,5005,525-50%-$445,500
D
2017-09-01
BLUEBluebird Bio, Inc.Gregory Philip DChief Scientific OfficerS - Sale+OE$126.06-2,25029,484-7%-$283,635
D
2017-09-01
BLUEBluebird Bio, Inc.Davidson DavidChief Medical OfficerS - Sale+OE$129.07-12,00015,977-43%-$1,548,904
2017-09-01
GNMCAevi Genomic Medicine, Inc.Harper Philip R10%P - Purchase$1.20+83,7755,179,819+2%+$100,530
D
2017-08-31
LIFEAtyr Pharma IncSchimmel PaulDirP - Purchase$2.65+94,3361,140,171+9%+$249,990
D
2017-08-31
LIFEAtyr Pharma IncMendlein JohnCEO, DirP - Purchase$2.65+37,736367,883+11%+$100,000
D
2017-08-31
SGENSeattle Genetics Inc /waDobmeier EricCOOS - Sale+OE$52.24-25,000117,424-18%-$1,305,893
D
2017-08-31
SGENSeattle Genetics Inc /waCline Darren SEVP, CommercialS - Sale+OE$52.51-7,56972,206-9%-$397,466
DM
2017-08-31
CRSPCrispr Therapeutics AGNovak RodgerCEOS - Sale+OE$20.76-18,4701,148,007-2%-$383,393
2017-09-01
EIGREiger Biopharmaceuticals, Inc.Glenn Jeffrey SDirP - Purchase$9.53+15,000182,879+9%+$142,950
D
2017-08-31
GILDGilead Sciences IncMeyers James REVP Worldwide Commercial OpsS - Sale+OE$83.19-60,0002,715-96%-$4,991,290
D
2017-09-01
AVXSAvexis, Inc.Nagendran SukumarSVP, Chief Medical OfficerS - Sale+OE$93.25-1,7800-100%-$165,978
D
2017-08-31
BLUEBluebird Bio, Inc.Walsh Jeffrey T.Chief FinancialS - Sale+OE$125.01-12,00027,305-31%-$1,500,091
D
2017-08-31
BLUEBluebird Bio, Inc.Schenkein David PDirS - Sale+OE$115.07-2,0003,176-39%-$230,145
D
2017-08-31
BLUEBluebird Bio, Inc.Lynch DanielDirS - Sale+OE$120.00-5002,800-15%-$60,000
DM
2017-08-31
BLUEBluebird Bio, Inc.Leschly NickPres, CEOS - Sale+OE$122.27-46,833290,418-14%-$5,726,444
DM
2017-08-31
MNTAMomenta Pharmaceuticals IncWheeler Craig APresS - Sale+OE$17.00-20,367553,092-4%-$346,239
D
2017-09-01
SGMOSangamo Therapeutics, IncHerberts Curt A. IIISr.VP, Chief Business OfficerS - Sale+OE$15.00-15,00015,833-49%-$225,000
D
2017-09-01
BOLDAudentes Therapeutics, Inc.Prasad SuyashSVP, Chief Med OfficerS - Sale+OE$21.44-8,0000-100%-$171,481
D
2017-08-30
GILDGilead Sciences IncAlton Gregg HEVP Comm, Acs ALA, Corp, Med AS - Sale+OE$79.00-50,00084,238-37%-$3,950,000
D
2017-08-29
ONCESpark Therapeutics, Inc.High Katherine ASee RemarksS - Sale+OE$80.25-10,000210,000-5%-$802,541
2017-08-31
NVAXNovavax IncYoung James FDirS - Sale$1.06-175,0000-100%-$184,870
2017-08-29
JUNOJuno Therapeutics, Inc.Azelby RobertEVP, Chief Commercial OfficerS - Sale$39.95-12,86950,289-20%-$514,117
2017-08-31
HSKAHeska CorpWisnewski NancyEVP, Diag. Ops, Prod. Dev.S - Sale$102.21-82538,114-2%-$84,327
D
2017-08-30
HSKAHeska CorpMcMahon JohnVP, CFOS - Sale+OE$101.17-2,60868-97%-$263,857
2017-08-29
ACORAcorda Therapeutics IncScopia Capital Management LP10%P - Purchase$19.23+766,2018,474,728+10%+$14,730,449
2017-08-30
BLUEBluebird Bio, Inc.Leschly NickPres, CEOS - Sale$115.18-25,667330,887-7%-$2,956,307
2017-08-31
BCLIBrainstorm Cell Therapeutics Inc.Arbel IritDirP - Purchase$4.26+2,500155,833+2%+$10,650
D
2017-08-29
CELZCreative Medical Technology Holdings, Inc.Warbington TimothyCEO, Pres, 10%S - Sale+OE$0.20-5,00065,122,5940%-$1,000
D
2017-08-29
CELZCreative Medical Technology Holdings, Inc.Creative Medical Health Inc.10%S - Sale+OE$0.20-5,00058,655,9270%-$1,000
2017-08-28
SGENSeattle Genetics Inc /waSimpson Todd ECFOS - Sale$47.89-4,937228,015-2%-$236,455
2017-08-28
SGENSeattle Genetics Inc /waSiegall Clay BPres, CEOS - Sale$47.89-25,506678,129-4%-$1,221,597
2017-08-28
SGENSeattle Genetics Inc /waHimes Vaughn BChief Technical OfficerS - Sale$47.89-6,377164,906-4%-$305,423
2017-08-28
SGENSeattle Genetics Inc /waDrachman Jonathan GCMO, EVP, R, DS - Sale$47.89-8,502133,702-6%-$407,199
2017-08-28
SGENSeattle Genetics Inc /waDobmeier EricCOOS - Sale$47.89-5,343117,424-4%-$255,900
2017-08-28
SGENSeattle Genetics Inc /waCline Darren SEVP, CommercialS - Sale$47.89-1,78876,868-2%-$85,635
DM
2017-08-28
CRSPCrispr Therapeutics AGNovak RodgerCEOS - Sale+OE$20.25-75,7951,162,624-6%-$1,534,869
M
2017-08-28
CRSPCrispr Therapeutics AGKulkarni SamarthChief Business OfficerS - Sale$20.08-27,154106,893-20%-$545,162
2017-08-28
CRSPCrispr Therapeutics AGEmster Kurt VonDirS - Sale$19.79-88,0111,951,359-4%-$1,741,738
D
2017-08-28
BLUEBluebird Bio, Inc.Walsh Jeffrey T.Chief FinancialS - Sale+OE$107.06-1,25027,305-4%-$133,826
2017-08-25
CVMCel Sci CorpTalor EyalChief Scientific OfficerS - Sale$1.91-769118,543-1%-$1,469
M
2017-08-24
CRSPCrispr Therapeutics AGEmster Kurt VonDirS - Sale$19.42-22,7812,039,370-1%-$442,403
DM
2017-08-24
BLUEBluebird Bio, Inc.Maraganore JohnDirS - Sale+OE$96.00-13,8395,843-70%-$1,328,533
D
2017-08-24
SGENSeattle Genetics Inc /waDrachman Jonathan GCMO, EVP, R, DS - Sale+OE$47.54-10,000142,204-7%-$475,414
2017-08-23
BTXBiotime IncSkibsted RussellCFOP - Purchase$2.64+2,0002,000New+$5,285
D
2017-08-24
BOLDAudentes Therapeutics, Inc.Newman MarySVP, Regulatory AffairsS - Sale+OE$20.00-10,0000-100%-$200,000

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top